am j ophthalmol 2014 rahimy-3
TRANSCRIPT
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 1/10
Paracentral Acute Middle Maculopathy in NonischemicCentral Retinal Vein Occlusion
EHSAN RAHIMY, DAVID SARRAF, MICHAEL L. DOLLIN, JOHN D. PITCHER, AND ALLEN C. HO
PURPOSE: To better characterize a novel spectral-domain optical coherence tomography (OCT) presenta-
tion, termed paracentral acute middle maculopathy, to
describe this finding in patients with nonischemic centralretinal vein occlusion (CRVO), and to support a proposed
pathogenesis of intermediate and deep retinal capillary
ischemia. DESIGN: Retrospective observational case series. METHODS: Clinical histories, high-resolution digitalcolor imaging, red-free photography, fluorescein angiog-
raphy, near-infrared reflectance, and spectral-domainOCT images of 484 patients with acute CRVO from 2centers were evaluated for the presence of coexisting
paracentral acute middle maculopathy. RESULTS: Of 484 patients diagnosed with CRVO, 25(5.2%) demonstrated evidence of concurrent paracentral
acute middle maculopathy. Patients averaged 51 years ofage and presented with complaints of paracentral sco-
tomas. All patients demonstrated hyper-reflective plaque-like lesions at the level of the inner nuclear layer by
spectral-domain OCT and showed corresponding dark-
gray lesions on near-infrared reflectance and perivenular
deep retinal whitening on color fundus photography.There was no fluorescein angiographic correlate to these
lesions. On follow-up spectral-domain OCT imaging, thelesions had resolved into areas of inner nuclear layer atro-
phy with persistence of scotomas. CONCLUSIONS: Paracentral acute middle maculopathy
refers to characteristic hyper-reflective spectral-domain
OCT lesions involving the middle layers of the retina atthe level of the inner nuclear layer that may develop in
response to ischemia of the intermediate and deep capil-
lary plexuses. This series is the largest to describe thisspectral-domain OCT finding to date, and it is the first
to associate it with nonischemic CRVO. (Am JOphthalmol 2014;158:372–380. 2014 by Elsevier
Inc. All rights reserved.)
RECENTLY, WE IDENTIFIED CHARACTERISTIC BAND-
like hyper-reflective spectral-domain optical coher-
ence tomography (OCT) lesions in patients with
presumed acute macular neuroretinopathy involving themiddle layers of the retina at the level of the inner nuclear
layer, a novel finding we termed paracentral acute middle
maculopathy.1,2 Since these initial reports, a smaller caseseries additionally observed this finding in 4 patients,
including 1 with underlying diabetic retinopathy.3 Retinalcapillary ischemia has been proposed as the causative factor
in the development of these lesions, which localize histo-logically at the level of the intermediate and deep retinalcapillary plexuses flanking the inner and outer boundaries
of the inner nuclear layer, respectively.1,4
This article describes 25 new cases of paracentral acutemiddle maculopathy occurring in association with acute
nonischemic central retinal vein occlusion (CRVO), andwill help to further elucidate the underlying pathogenesis
of these middle retinal lesions.
METHODSINSTITUTIONAL REVIEW BOARD APPROVAL FOR THIS
retrospective 2-center study was obtained through the
Wills Eye Hospital, Philadelphia, Pennsylvania, and theUniversity of California, Los Angeles, Office of the Human
Research Protection Program. Research adhered to the
tenets of the Declaration of Helsinki and was conductedin accordance with regulations set forth by the HealthInsurance Portability and Accountability Act.
Using International Classification of Diseases, 9th Revi-
sion (ICD-9), billing codes for CRVO, 2 of our authors(ER, DS) reviewed the spectral-domain OCT imaging
database at each of their retinal care centers and studied
the findings of 484 cases of CRVO diagnosed between January 2010 and September 2013. We identified 25 cases
of acute CRVO with simultaneous acute paracentral acutemiddle maculopathy lesions and assessed the clinical and
imaging data for each case, focusing primarily on multi-
modal imaging correlations. Baseline and follow-up demo-graphic, clinical and laboratory data were extracted from
patient charts and analyzed. Statistical analysis was
performed by a simple 2-tailed t test using GraphPad Soft-ware (GraphPad, La Jolla, California).
High-resolution digital color imaging, red-free photog-
raphy, and fluorescein angiography at baseline presentation
Accepted for publication Apr 23, 2014.From Mid Atlantic Retina, The Retina Service of Wills Eye Hospital,
Thomas Jefferson University, Philadelphia, Pennsylvania (E.R., M.L.D., J.D.P., A.C.H.); the Retinal Disorders and Ophthalmic GeneticsDivision, Jules Stein Eye Institute, University of California, LosAngeles, David Geffen School of Medicine, Los Angeles, California(D.S.); and the Greater Los Angeles Veterans Affairs HealthcareCenter, Los Angeles, California (D.S.).
Inquiries to Allen C. Ho, Mid Atlantic Retina, The Retina Service of
Wills Eye Hospital, Thomas Jefferson University, Philadelphia,Pennsylvania; e-mail: [email protected]
372 0002-9394/$36.00http://dx.doi.org/10.1016/j.ajo.2014.04.024
2014 BY ELSEVIER INC. ALL RIGHTS RESERVED.
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 2/10
were analyzed, when available, for each patient. Initial
near-infrared reflectance and spectral-domain OCT exami-
nations utilizing the Heidelberg Spectralis (HeidelbergEngineering, Heidelberg, Germany) were evaluated at base-
line in every patient and correlated with subsequent follow-
up scans during the course of a patient’s follow-up whenavailable. We used the registration feature specific to Hei-
delberg Spectralis, which allows each spectral-domainOCT B-scan to be coupled to its exact location on the
near-infrared reflectance image, facilitating point-to-pointcorrelations of the retinal findings between the near-
infrared reflectance and spectral-domain OCT images.
RESULTS
OF THE 484 PATIENTS DIAGNOSED WITH CRVO, 25 (5.2%)
demonstrated evidence of concurrent paracentral acute mid-
dle maculopathy at the time of their initial office evaluations.Baseline patient demographics and ocular examination find-
ings in these eyes are outlined in the Table. The mean age atpresentation was 51 years (range, 19–78; standard deviation
(SD), 16.6) in the group with paracentral acute middle
maculopathy, which was significantly younger than the69.6 years (range, 20 to 95; SD, 13.9) in the remainder of
the patients with CRVO (P < .001). There was no genderpredilection for the development of paracentral acute middle
maculopathy (males, 48%; females, 52%).
With respect to pre-existing systemic and ocular comor-bidities, 8 patients had known histories of hypertension, 6
had hypercholesterolemia, 4 had diabetes mellitus, 3 hadsystemic lupus erythematosus, 3 had open-angle glaucoma
with optic disc cupping, and 1 had active pulmonary tuber-culosis who was undergoing treatment. After detailed his-
tories were obtained, 2 patients endorsed current use of
oral contraceptive pills, and 1 individual was a long-distance marathon runner. Hematologic laboratory
workup, when obtained, was negative for any hypercoagu-
lable state in all but 1 case, in which an underlying diag-nosis of monoclonal gammopathy of undetermined
significance was uncovered.Patients typically presented with subjective central
visual deficits that began, on average, 8.3 days prior to officeevaluation (range, 1–21 days). Complaints ranged fromgeneralized blurring of the central vision and difficulty
focusing to more specific patterns of paracentral scotomas,
including the following patient descriptions: ‘‘pieces of cen-tral vision missing’’ (Figure 1); ‘‘concentrically arrangedfixed gray spots’’; ‘‘like looking through cracked glass’’;
‘‘numerous small blind spots’’; and ‘‘blank spots in central
vision.’’ On initial examination, Snellen best-correctedvisual acuity (BCVA) ranged from 20/20 to hand motions,
with an average of 20/120 (logarithm of minimal angle of
resolution [logMAR] equivalent, 0.76). The vast majority
of eyes demonstrated good initial acuity, with 14 (56%)
of 25 patients presenting with BCVA of 20/50 or better;however, 8 (32%) of 25 had vision of 20/200 or worse, all
of which were noted to have concurrent cilioretinal artery
occlusion (Figure 2). Altogether, simultaneous cilioretinalartery occlusion was a common occurrence in our cohort
(10 (40%) of 25 patients), and their mean BCVA of 20/800 (logMAR equivalent, 1.60) was significantly lower
than the 20/40 (logMAR equivalent: 0.26) for nonciliore-tinal artery occlusion patients (P < .001).
The diagnosis of CRVO was established on the basis of
characteristic funduscopic findings: tortuosity and dilata-
tion of the central retinal vein, intraretinal hemorrhagesthroughout all 4 quadrants, and/or optic disc and macularedema. In all eyes, detailed examination of the macula in
the involved eye revealed patchy areas of deep retinal whit-
ening centered within the macula, often in the distributionof the venous tributaries and always correlating with para-
central acute middle maculopathy on spectral-domain
OCT (Figures 1–6). Compared to cotton-wool spots, the
retinal whitening associated with paracentral acute middle
TABLE. Patient Demographics and Ocular Findings in
Paracentral Acute Middle Maculopathy
Age, years
Mean 6 SD 51 6 16.6
Range 19–78
Gender (n ¼ 25)
Male 12 (48%)
Female 13 (52%)
Eye (n ¼ 25)
Right 12 (48%)
Left 13 (52%)
CRVO Type (n ¼ 25)
Nonischemic 25 (100%)
Ischemic 0 (0%)
Systemic/ocular associations
Hypertension 8 (32%)
Hypercholesterolemia 6 (24%)
Diabetes mellitus 4 (16%)
SLE 3 (12%)
Open-angle glaucoma 3 (12%)
OCP use 2 (8%)
Marathon running 1 (4%)
MGUS 1 (4%)
BCVA
Snellen mean 20/120
Snellen range 20/20-HM
logMAR mean 0.767
logMAR range 0–2.28
BCVA ¼ best-corrected visual acuity; CRVO ¼ central retinal
vein occlusion; HM ¼ hand motions; logMAR ¼ logarithm of
the minimum angle of resolution; MGUS ¼ monoclonal gammop-
athy of undetermined significance; OCP ¼ oral contraceptive
pills; SD ¼ standard deviation; SLE ¼ systemic lupus erythema-
tosus.
VOL. 158, NO. 2 373PARACENTRAL ACUTE MIDDLE MACULOPATHY IN VEIN OCCLUSION
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 3/10
maculopathy was noticeably distinct, appearing as a duller
gray-white in color, less opaque, deeper in the retina, and
not following the distribution of the nerve fiber layer
(Figure 3). Similarly, the lesions of paracentral acute mid-dle maculopathy were uniquely different in appearance andlocation from associated cilioretinal artery occlusion, when
present (Figure 2), which was more superficial and whiter.
Because of the presence of concurrent retinal hemor-rhages and cotton-wool spots, the extent of paracentral
acute middle maculopathy was not always as readily
apparent on examination; however, with ancillary red-free photography (Figure 4) and near-infrared reflectance
imaging (Figures 1–6), the lesions were more clearlyidentified, appearing dark and more precisely delineated.
Specifically, near-infrared reflectance confirmed the peri-
venular location of paracentral acute middle maculopathyin the majority of cases. Conversely, the fluorescein angio-
gram had no correlation with the lesions (Figure 1 andFigure 4), and no cases displayed angiographic evidence
of an ischemic CRVO (10 or greater disc diameters of capil-
lary nonperfusion).Corresponding spectral-domain OCT imaging registered
through the zones of retinal whitening revealed multifocalhyper-reflective plaquelike lesions at the level of the inner
nuclear layer (Figures 1–6). In 13 cases, the involvement of
paracentral acute middle maculopathy was additionallynoted to extend into the inner plexiform layer. Although
the lesions appeared to cast a shadow over the deeper
retinal layers, they spared the ellipsoid and interdigitation
bands, which were always intact by spectral-domain OCT.
Associated macular edema was an uncommon finding,
noted in the spectral-domain OCT scans of only 5 (20%)of 25 patients.
Mean duration of follow-up was 7.2 months (range,
1–24; median, 4; SD, 7.6), although 8 of the 25 patients
were lost to follow-up. Average final BCVA at the mostrecent clinic visit was 20/40 (logMAR equivalent, 0.339)
for the entire cohort. More specifically, patients with simul-
taneous cilioretinal artery occlusion experienced partialresolution of vision back to an average BCVA of 20/120
(logMAR equivalent, 0.81), compared to 20/30 (logMARequivalent, 0.20) in the noncilioretinal artery occlusion
patients (P ¼ 0.26). Although 14 (82%) of the 17 patients
tested 20/50 or better at the final visit, the subjective para-central scotomas persisted.
On fundus examination, intraretinal hemorrhages, opticdisc edema and macular edema showed variable degrees of
resolution. On follow-up near-infrared reflectance imaging,
the dark lesions had dissipated, and the most recentspectral-domain OCT examinations revealed zones of
severe inner nuclear layer thinning and a markedly attenu-ated outer plexiform layer band where the hyper-reflective
paracentral acute middle maculopathy lesions had been
located previously (Figure 5 and Figure 6). The shadowinginduced by the overlying lesions seen on spectral-domain
OCT had resolved.
FIGURE 1. Patient 1, with paracentral acute middle maculopathy. A 37-year-old female receiving therapy for active pulmonary
tuberculosis presented with acute vision loss in the right eye and noted that ‘‘pieces of central vision were missing,’’ as illustrated
by Amsler grid testing (Top left). Visual acuity was 20/25 at presentation, and retinal examination of the right eye (Top middle)
was consistent with acute central retinal vein occlusion and perivenular retinal whitening in the temporal macula (solid arrow). Fluo-
rescein angiography (Top right) was unremarkable. Near-infrared reflectance imaging (Bottom left) demonstrated multifocal dark
gray lesions at the terminal tips of the venous branches corresponding to the retinal whitening observed clinically. Spectral-
domain optical coherence tomography revealed multiple hyper-reflective plaquelike lesions involving the inner nuclear layer (Bottom
right, solid arrows) consistent with paracentral acute middle maculopathy.
374 AUGUST 2014AMERICAN JOURNAL OF OPHTHALMOLOGY
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 4/10
Of the patients, 5 had received serial intravitreal anti-
vascular endothelial growth factor therapy during their
courses (2 with bevacizumab, 3 with ranibizumab) for treat-ment of associated macular edema. Whether a patient
received intravitreal injections did not appear to impactthe timeline to resolution of the paracentral acute middle
maculopathy.
DISCUSSION
PARACENTRAL ACUTE MIDDLE MACULOPATHY REFERS TO
a recently recognized class of characteristic lesions invol-
ving the middle layers of the retina at the level of the inne rnuclear layer as detected by spectral-domain OCT imaging.1
The present study is the largest to date characterizing this
entity and is the first to show its association with nonische-
mic CRVO. The association of paracentral acute middle
maculopathy with disparate disorders such as acute macular
neuroretinopathy and CRVO may indicate that these
lesions seen on spectral-domain OCT have a wide spectrumof presentation, such that they can occur as isolated events
in typically healthy patients with acute macular neuroretin-opathy and can also occur in various retinal vascular disor-
ders such as CRVO, in which multiple middle retinallesions are identifiable. In either case, the characteristicappearance may be the result of an ischemic insult at the
level of the inner nuclear layer,as thelocationof paracentral
acute middle maculopathy on spectral-domain OCT corre-sponds histologically with the intermediate and deep capil-lary plexuses, and subsequent atrophy of the inner nuclear
layer ensues, often with persistent subjective scotoma.
In 2002, Browning5 published a study concerning 11patients with nonischemic CRVO in whom he noted a
transient pattern of patchy ischemic retinal whitening
located preferentially in a perivenular distribution around
the macula. He proposed that because the oxygen
FIGURE 2. Patient 2, with paracentral acute middle maculopathy. A 68-year-old male with diabetes mellitus and hypertension
presented with acute vision loss in the left eye. Visual acuity was counting fingers, at presentation, and funduscopy of the left eye
(Top left) was consistent with acute central retinal vein occlusion and associated cilioretinal artery occlusion (broken arrow). In
the temporal macula, a subtle pattern of retinal whitening was noted around the venous branches (Top left, solid arrow). Near-
infrared reflectance imaging (Top right) demonstrated dark-gray lesions in the distribution of the cilioretinal artery (broken arrow)
and temporal perivenular branches (solid arrow). Spectral-domain optical coherence tomography displayed hyper-reflective plaquelike
lesions involving the inner nuclear layer (Bottom, solid arrow) in the temporal macula, consistent withparacentral acute middle macul-
opathy in contrast to the superficial edema and hyper-reflectivity induced by the cilioretinal artery occlusion (Bottom, broken arrow).
VOL. 158, NO. 2 375PARACENTRAL ACUTE MIDDLE MACULOPATHY IN VEIN OCCLUSION
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 5/10
saturation of blood diminishes during transit to the venous
system, the tissue adjacent to veins becomes exposed to the
lowest oxygen levels. Thus, in the setting of CRVO, themost sensitive tissue for manifesting decreased oxygenation
will be perivenular, especially in the posterior pole, where
oxygen metabolism is highest. In 2003, Paques and associ-ates6 reported on 3 additional patients with CRVO display-
ing this pattern of macular perivenular whitening in a‘‘fern-like’’ distribution. Neither of these reports, however,
had the benefit of ancillary spectral-domain OCT imaging.
It is clear that these described syndromes correlate withthe characteristic paracentral acute middle maculopathy
lesions seen by spectral-domain OCT in our 25 cases of CRVO described in this article, because 3 additional case
reports corroborating these multimodal imaging findings
have since been reported in the literature.7–9 Michaelsonand others have previously emphasized the presence of a
zone surrounding the retinal arteries devoid of any
capillaries.10,11 The veins, on the other hand, do not
have a capillary-free zone. Rather, the capillaries are
thought to be densest about the venular portions of thecapillary meshwork.10 Such a distribution may help to
explain the likelihood of the paracentral acute middle
maculopathy we detected to be perivenular in distribution.The main branches of the central retinal artery and vein
course horizontally throughout the superficial nerve fiberlayer with occasional dips into the deeper layers.12 From
the terminal arterioles and venules, precapillary and capil-
lary branches emerge, often at near right angles to the sur-face of the retina. These tributaries then dive into the
deeper retinal layers where they then anastomose laterallyand form an intricate, planar microvascular capillary
network.12 In their seminal work published in 1954,
Michaelson and Campbell10 emphasized a laminar distribu-tion of these capillaries that varied in differing regions of
the retina. Outside the cecocentral area, they proposed
FIGURE 3. Patient 3, with paracentral acute middle maculopathy. A 19-year-old healthy female taking oral contraceptive pills
presented with acute onset of a fixed ‘‘blue spot’’ in the center of her left visual field. Visual acuity was 20/30, and ophthalmoscopy
of the left eye (Top left) revealed an acute central retinal vein occlusion with perivenular retinal whitening along the tributaries of thesuperotemporal arcade (solid arrow). Near-infrared reflectance imaging (Top right) demonstrated perivenular dark-gray lesions (solid
arrow) in the distribution of the retinal whitening observed clinically. Spectral-domain optical coherence tomography showed mul-
tiple hyper-reflective lesions involving the inner nuclear layer (Bottom, solid arrows) consistent with paracentral acute middle macul-
opathy.
376 AUGUST 2014AMERICAN JOURNAL OF OPHTHALMOLOGY
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 6/10
that 2 laminas were present: a superficial capillary plexus in
the nerve fiber layer and a deep capillary plexus at the junc-tion of the inner nuclear and outer plexiform layers. In the
macular region, the deep plexus was then believed to split,
forming an additional plexus between the inner plexiformand inner nuclear layers. Terminology notwithstanding,
this 3-dimensional conceptualization of the retinal micro-
vascular network still stands today.4,13,14 In most higher
order mammals, it is recognized that 3 planar capillary
plexuses form during development: (1) the superficialplexus forms within the ganglion cell layer; (2) the
intermediate and (3) the deep vascular plexuses form at
the inner and outer edges of the inner nuclear layer,respectively.4 In postmortem studies of human donor
eyes, Tan and associates14 identified each of these 3 layers
in addition to a layer at the nerve fiber layer level.
FIGURE 4. Patient 4, with paracentral acute middle maculopathy. A 68-year-old female with hypertension presented with ‘‘fixed
spots’’ in the central vision of the left eye. Visual acuity was 20/200 at presentation, and retinal examination (Top left) demonstrated
an acute central retinal vein occlusion. In the temporal macula, subtle perivenular retinal whitening was observed (Top left, solid
arrow), which was enhanced by red-free imaging (Top middle, solid arrow). Fluorescein angiography was unremarkable (Top right);
however, near-infrared reflectance imaging (Bottom left) uncovered ‘‘fern-like’’ perivenular dark grey lesions corresponding to the
retinal whitening observed clinically. Spectral-domain optical coherence tomography demonstrated multiple hyper-reflective plaque-
like lesions involving the inner nuclear layer (Bottom right, solid arrows) consistent with paracentral acute middle maculopathy.
FIGURE 5. Patient 5, with paracentral acute middle maculopathy. A 19-year-old healthy male presented with acute vision loss in the
left eye. Visual acuity was 20/50 at presentation, and retinal examination (Left) demonstrated an acute central retinal vein occlusion.
Retinal whitening in the distribution of the cilioretinal artery (Left, broken arrow) and around the venous branches in the temporal
macula (Left, solid arrow) was visualized. Near-infrared reflectance imaging (Top middle) demonstrated dark gray lesions correspond-
ing to these patches of retinal whitening. Spectral-domain optical coherence tomography (OCT) displayed multiple hyper-reflective
plaquelike lesions involving the inner nuclear layer (Top right, solid arrows) consistent with paracentral acute middle maculopathy.At 4-week follow-up, the near-infrared lesions (Bottom middle) were resolving, while corresponding spectral-domain OCT scans
showed partial resolution of the hyper-reflective lesions as well as multiple zones of inner nuclear layer thinning and an irregular,
attenuated outer plexiform layer (Bottom right, solid arrows) without any visible funduscopic correlate.
VOL. 158, NO. 2 377PARACENTRAL ACUTE MIDDLE MACULOPATHY IN VEIN OCCLUSION
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 7/10
The most critical function of the retinal circulation is tosupply oxygen.15 It has been reported that the deep capillary
plexus contributes 10%–15% of the oxygen supply to thephotoreceptor population.16 The photoreceptor axon termi-
nals, located in the outer plexiform layer, are replete with
oxygen-dependent mitochondria, as demonstrated by Stone
and associates,
17
and may rely more heavily on the deepcapillary plexus for oxygen supply than the photoreceptor
inner and outer segments located closer to the underlyingchoriocapillaris. A steady decline of the diffusion gradientof oxygen from the choriocapillaris to the photoreceptor
axons has been experimentally confirmed by Wangsa-
Wirawan and associates.18 Similarly, studies of cat retinashave demonstrated that oxygen tension in the retina is high-
est near the choroid, bottoms out at the level of the outer
nuclear layer, and then rises again in the superficial retinallayers.19,20 The location of the minimum oxygen tension is
assumed to be located in a watershed region, where
oxygen contribution may be provided by both thechoroidal and retinal circulations.13,21 As such, the outer
plexiform layer and adjacent inner nuclear layer in thiswatershed zone may be especially vulnerable to ischemic
insults to the intermediate and deep capillary plexuses.
In our study, the extent of paracentral acute middlemaculopathy on spectral-domain OCT was noted toinvolve primarily the full thickness of the inner nuclear
layer and, in nearly half of cases, advanced into the over-
lying inner plexiform layer. Subsequently, the lesionsinvariably resolved with thinning of the inner nuclear
layer. That this lesion aligns precisely with the intermedi-
ate and deep capillary plexuses, and given our cohorts’
underlying diagnoses of CRVO coupled with vasculopathicrisk factors, we propose that ischemia of these microvas-
cular networks is the likely cause of the observed lesions.The extent of inner plexiform layer involvement, when
noted, may be representative of a more severe ischemic
insult to the adjacent intermediate capillary plexus. It is
important to emphasize that traditional imaging tech-niques such as fluorescein angiography cannot assess
adequately the morphology or the integrity of these deeperretinal capillary plexuses, as previously demonstrated byMendis and associates.22
As in previous studies,5,6 we similarly observed that
patients with CRVO and paracentral acute middlemaculopathy (1) tend to be younger, (2) do not appear to
demonstrate any consistent systemic disease association,
(3) often have a negative laboratory workup in search of coagulation abnormalities or inflammatory disorders, (4)
present with nonischemic CRVO, and (5) have a higher
association of cilioretinal artery occlusion (40%).Although the proposed pathophysiologic mechanism of
combined CRVO and cilioretinal artery occlusion is widelydebated, the association of paracentral acute
middle maculopathy with cilioretinal artery occlusion
cannot be overlooked. Presumably, cilioretinal arteryocclusion occurs due to the lower arteriolar pressure of thecilioretinal artery compared with that of the central retinal
artery.23–25 Therefore, a sudden occlusion of the central
retinal vein results in a marked rise of the intraluminalpressure that is transmitted throughout the entire retinal
capillary bed.26 Once the intraluminal pressure rises above
that in the already susceptible cilioretinal artery system,
FIGURE 6. Patient 6, with paracentral acute middle maculopathy. A 56-year-old previously healthy female presented with acute
onset ‘‘difficulty focusing’’ with the right eye. Visual acuity was 20/60 at presentation, and funduscopy (Top left) revealed an acute
central retinal vein occlusion and extensive perivenular retinal whitening in the macula (solid arrow). Near-infrared reflectance
imaging (Top middle) demonstrated ‘‘fern-like’’ perivenular dark grey lesions corresponding to the retinal whitening observed clin-
ically. Spectral-domain optical coherence tomography (OCT) revealed multiple hyper-reflective bands involving the inner nuclear
layer (Top right, solid arrows) consistent with paracentral acute middle maculopathy. A subsequent hematologic work-up uncovered
an underlying diagnosis of monoclonal gammopathy of undetermined significance. At 3-week follow-up, the perivenular retinal whit-
ening was clinically resolving (Bottom left), as were the near-infrared lesions (Bottom middle). The corresponding spectral-domain
OCT scans showed partial resolution of the hyper-reflective lesions and multiple zones of inner nuclear layer thinning plus an irreg-
ular, attenuated outer plexiform layer (Bottom right, solid arrows).
378 AUGUST 2014AMERICAN JOURNAL OF OPHTHALMOLOGY
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 8/10
the result is a relative hemodynamic blockade in the artery,
manifesting as a cilioretinal artery occlusion.26 The possibil-
ity that increased venous intraluminal pressure couldadversely affect other regions of potential vascularinstability,
such as that in the watershed zone subserved by the deep and/
or intermediate capillary plexuses, is an intriguing one. If so,CRVO with paracentral acute middle maculopathy may
serve as an intermediate disease state in the progressionfrom nonischemic CRVO to combined nonischemic
CRVO and cilioretinal artery occlusion formation.Only 20% of the patients in this current study had coex-
isting macular edema at the time of presentation. The pres-
ence of retinal heme or edema may limit the ability todetect paracentral acute middle maculopathy. Further-
more, these lesions are evanescent and may resolve priorto clinical detection. Therefore, the incidence of paracen-
tral acute middle maculopathy in all cases of CRVO may
actually be much higher than the 5.2% we observed. Themultifocal arrangement of paracentral acute middle macul-
opathy we observed in the setting of nonischemic CRVO isunique because our previously reported series describedonly solitary lesions.1 Over time, the hyper-reflective bandsdetected on spectral-domain OCT evolved into atrophy
with attenuation of the inner nuclear and outer plexiform
layers, accounting for persistent scotomas noted onfollow-up examinations as far out as 24 months in certain
patients. Many of these subjective complaints, outlined
in the Results section, may be overlooked, especiallywhen the BCVA is preserved and there is no evidence of
macular edema or underlying angiographic abnormalities.It is important, therefore, for ophthalmologists to identify
paracentral acute middle maculopathy on spectral-domain OCT and to counsel patients accordingly, espe-cially if there are corresponding visual sequelae.
Limitations of our study include its retrospective nature,
the relatively small number of eyes (25) studied, and the
high number of patients (8) without clinical follow-up. Nevertheless, this is the largest case series to date
describing this unique finding of paracentral acute middle
maculopathy in the setting of nonischemic CRVO. Wehave provided clinical and anatomic evidence to support
retinal capillary ischemia as the cause of paracentral acutemiddle maculopathy, but this proposed mechanism has not
yet been proven. Showing causality would require animalmodels of retinal capillary occlusion and subsequent
demonstration of the characteristic findings of paracentral
acute middle maculopathy with multimodal imaging. Moreadvanced imaging systems to identify abnormalities in the
intermediate and deep capillary plexuses will furtherenhance our understanding of paracentral acute middle
maculopathy. More recently, Wang and associates27 have
used ultrahigh-resolution OCT and adaptive optics toimage the retinal capillary system at 3-dimensional resolu-
tion.In summary, paracentral acute middle maculopathy re-
fers to characteristic hyper-reflective spectral-domainOCT lesions involving the middle layers of the retina at
the level of the inner nuclear layer that develop in response
to ischemia of the intermediate and deep capillary plexuses.This series describes in particular paracentral acute middle
maculopathy in the setting of coexisting nonischemic
CRVO; however, it appears that this is a unique entitythat may coexist in various retinal vascular disorders, anal-
ogous to a deeper cotton-wool spot in the middle retina.This finding is probably much more common than has
been reported to date, and additional cases may be identi-fied as the ophthalmic community becomes more aware of its presentation and diagnosis.
ALL AUTHORS HAVE COMPLETED AND SUBMITTED THE ICMJE FORM FOR DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST,andthe following were reported.Dr Sarrafis a speaker forHeidelberg andreceivesgrantsupport from Regeneron. Dr Ho is a paid consultant andlecturerforAlcon. Contributions of Authors: Concept and design (E.R., D.S., A.C.H.); Analysis and interpretation of data (E.R., D.S., M.L.D., J.D.P., A.C.H.); andPreparation, review, or approval of manuscript (E.R., D.S., M.L.D., J.D.P., A.C.H.).
REFERENCES
1. SarrafD, Rahimy E, Fawzi AA, et al.Paracentral acute middle
maculopathy: a new variant of acute macular neuroretinop-
athy associated with retinal capillary ischemia. JAMA
Ophthalmol 2013;131(10):1275–1287.
2. Tsui I, Sarraf D. Paracentral acute middle maculopathy and
acute macular neuroretinopathy. Ophthalmic Surg Lasers Imag-
ing Retina 2013;44(6 Suppl):S33–S35.
3. Yu S, Wang F, Pang CE, Yannuzzi LA, Freund KB. Multi-
modal imaging findings in retinal deep capillary ischemia.
Retina 2013. Epub ahead of print.
4. Dorrell MI, Friedlander M, Smith LEH. Retinal vascu-
lar development. In: Joussen AM, Gardner TW,
Kirchhof B, Ryan SJ, eds. Pathogenesis of retinal vascular
disease. Berlin, Germany: Springer Berlin Heidelberg;
2007:24–37.
5. Browning DJ. Patchy ischemic retinal whitening in acute
central retinal vein occlusion. Ophthalmology 2002;109(11):
2154–2159.
6. Paques M, Gaudric A. Perivenular macular whitening during
acute central retinal vein occlusion. Arch Ophthalmol 2003;
121(10):1488–1491.
7. Sarda V, Nakashima K, Wolff B, Sahel JA, Paques M. Topog-
raphy of patchy retinal whitening during acute perfused
retinal vein occlusion by optical coherence tomography and
adaptive optics fundus imaging. Eur J Ophthalmol 2011;
21(5):653–656.
8. Pichi F, Morara M, Veronese C, Lembo A, Nucci P,
Ciardella AP. Perivenular whitening in central vein
VOL. 158, NO. 2 379PARACENTRAL ACUTE MIDDLE MACULOPATHY IN VEIN OCCLUSION
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 9/10
occlusion described by fundus autofluorescence and spectral-
domain optical coherence tomography. Retina 2012;32(7):
1438–1439.
9. Marc C, Gire J, Boulicot C, Guigou S. [Perivenular whitening
in central retinal vein occlusion demonstrated by ‘‘en-face’’
OCT]. J Fr Ophtalmol 2013;36(8):641–644.
10. Michaelson IC, Campbell AC. The anatomy of the finer
retinal vessels. Tr Ophth Soc U K 1940;60:71–76.
11. Hayreh SS. Acute retinal arterial occlusive disorders. Prog
Retin Eye Res 2011;30(5):359–394.
12. Toussaint D, Kuwabara T, Cogan DG. Retinal vascular pat-
terns, Part II: Human retinal vessels studied in three dimen-
sions. Arch Ophthalmol 1961;65:575–581.
13. Snodderly DM, Weinhaus RS, Choi JC. Neural-vascular rela-
tionships in central retina of macaque monkeys (Macaca
fascicularis). J Neurosci 1992;12(4):1169–1193.
14. Tan PE, Yu PK, Balaratnasingam C, et al. Quantitative
confocal imaging of the retinal microvasculature in the
human retina. Invest OphthalmolVis Sci 2012;53(9):5728–5736 .
15. Linsenmeier RA. Electrophysiological consequences of
retinal hypoxia. Graefes Arch Clin Exp Ophthalmol 1990;
228(2):143–150.
16. Birol G, Wang S, Budzynski E, Wangsa-Wirawan ND,
Linsenmeier RA. Oxygen distribution and consumption in
the macaque retina. Am J Physiol Heart Circ Physiol 2007;
293(3):H1696–H1704.
17. Stone J, van Driel D, Valter K, Rees S, Provis J. The locations
of mitochondria in mammalian photoreceptors: relation to
retinal vasculature. Brain Res 2008;11(89):58–69.
18. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen:
fundamental and clinical aspects. Arch Ophthalmol 2003;
121(4):547–557.
19. Linsenmeier RA. Effects of light and darkness on oxygen dis-
tribution and consumption in the cat retina. J Gen Physiol
1986;88(4):521–542.
20. Alder VA, Cringle SJ, Constable IJ. The retinal oxygen pro-
file in cats. Invest Ophthalmol Vis Sci 1983;24(1):30–36.
21. Alder VA, Cringle SJ. Vitreal and retinal oxygenation.
Graefes Arch Clin Exp Ophthalmol 1990;228(2):151–157.
22. Mendis KR, Balaratnasingam C, Yu P, et al. Correlation of
histologic and clinical images to determine the diagnostic
value of fluorescein angiography for studying retinal capi-
llary detail. Invest Ophthalmol Vis Sci 2010;51(11):
5864–5869.
23. McLeod D. Cilio-retinal arterial circulation in central retinal
vein occlusion. Br J Ophthalmol 1975;59(9):486–492.
24. Hayreh SS. Pathogenesis of visual field defects. Role of the
ciliary circulation. Br J Ophthalmol 1970;54(5):289–311.
25. Hayreh SS, Revie IH, Edwards J. Vasogenic origin of visual
field defects and optic nerve changes in glaucoma. Br J
Ophthalmol 1970;54(7):461–472.
26. Hayreh SS, Fraterrigo L, Jonas J. Central retinal vein occlu-
sion associated with cilioretinal artery occlusion. Retina
2008;28(4):581–594.
27. Wang Q, Kocaoglu OP, Cense B, et al. Imaging retinal capil-
laries using ultrahigh-resolution optical coherence tomogra-
phy and adaptive optics. Invest Ophthalmol Vis Sci 2011;
52(9):6292–6299.
380 AUGUST 2014AMERICAN JOURNAL OF OPHTHALMOLOGY
7/23/2019 Am J Ophthalmol 2014 Rahimy-3
http://slidepdf.com/reader/full/am-j-ophthalmol-2014-rahimy-3 10/10
Biosketch
Ehsan Rahimy, MD is currently a first-year vitreoretinal fellow at Wills Eye Hospital. He received his undergraduate degree
in Cellular & Molecular Biology from the University of Michigan, followed by medical school training at Baylor College of
Medicine. He most recently completed his residency in ophthalmology at the Jules Stein Eye Institute, UCLA.
VOL. 158, NO. 2 380.e1PARACENTRAL ACUTE MIDDLE MACULOPATHY IN VEIN OCCLUSION